ANTHEM TIMI 32

OBJECTIVE: To assess the efficacy and safety of anticoagulation with rNAPc2 in non-ST segment elevation acute coronary syndrome patients managed with an early invasive strategy.

View/Download
_______________________________________________________________________________

1. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. Giugliano RP, Wiviott SD, Stone PH, et al. J Am Coll Cardiol 2007;49:2398-407.
   | Abstract | Request Reprints |